FDA MedWatch - Cybersecurity Alert: Fresenius Kabi Agilia Connect Infusion System

If your email program has trouble displaying this email, view as a webpage. MedWatch - The FDA Safety Information and Adverse Event Reporting Program Cybersecurity Alert: Fresenius Kabi Agilia Connect Infusion System On Tuesday, December 21, 2021, the Cybersecurity and Infrastructure Security Agency (CISA) published a vulnerability disclosure ICSMA-21-355-01 on the Fresenius Kabi Agilia Connect Infusion System. Successful remote exploitation of these vulnerabilities could allow an attacker to gain access to sensitive information, modify settings, or perform arbitrary actions as an unauthorized user. Affected components requiring a software security patch include: Agilia Connect WiFi module of the pumps vD25 and prior Agilia Link+ v3.0 D15 and prior Vigilant Software Suite v1.0: Vigilant Centerium, Vigilant MasterMed and Vigilant Insight; and Agilia Partner maintenance software v3.3.0 and prior. Questions? If you have questions about this cybersecurity alert, contact cybermed@fda.hhs.gov Read More

Manage Subscriptions  |  Unsubscribe All  |  Help

This email was sent to edwardlorilla1986.paxforex@blogger.com using GovDelivery Communications Cloud on behalf of: U.S. Food and Drug Administration ·  10903 New Hampshire Ave · Silver Spring, MD ·  20993-0002 ·  1-888-INFO-FDA